Marimastat in Treating Patients With Stage III Non-small Cell Lung Cancer

Completed · Phase 3

Conditions studied: Lung Cancer

In brief

RATIONALE: Marimastat may stop the growth of non-small cell lung cancer by stopping blood flow to the tumor. PURPOSE: Randomized double-blinded phase III trial to determine the effectiveness of marimastat in treating patients who have residual stage III non-small cell lung cancer.

Key facts

Study ID

NCT00002911

Run by

ILEX Oncology Services, Incorporated

Starts

1996-12-01

Expected to finish

2004-05-01

Last updated by the study team

2013-12-18

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Comprehensive Cancer Institute of Huntsville — Huntsville, Alabama, United States
• Hematology Associates, Ltd. — Phoenix, Arizona, United States
• Marin Cancer Institute — Greenbrae, California, United States
• Scripps Clinic — La Jolla, California, United States
• Scripps Memorial Hospital Stevens Cancer Center — La Jolla, California, United States
• USC/Norris Comprehensive Cancer Center — Los Angeles, California, United States
• St. Joseph Hospital - Orange — Orange, California, United States
• John Wayne Cancer Institute — Santa Monica, California, United States
• Kaiser Permanente Medical Center - Vallejo — Vallejo, California, United States
• Rocky Mountain Cancer Center — Denver, Colorado, United States
• University of Colorado Cancer Center — Denver, Colorado, United States
• University of Connecticut Health Center — Farmington, Connecticut, United States
• Vincent T. Lombardi Cancer Research Center, Georgetown University — Washington D.C., District of Columbia, United States
• Comprehensive Cancer Center at JFK Medical Center — Atlantis, Florida, United States
• Radiation Therapy Associates - Fort Myers — Fort Myers, Florida, United States
• Oncology-Hematology Group of South Florida — Miami, Florida, United States
• Bay Area Oncology, MD'S, PA — Tampa, Florida, United States
• Rush-Presbyterian-St. Luke's Medical Center — Chicago, Illinois, United States
• University of Chicago Cancer Research Center — Chicago, Illinois, United States
• Community Hospitals of Indianapolis - Regional Cancer Center — Indianapolis, Indiana, United States
• Memorial Hospital of South Bend — South Bend, Indiana, United States
• Veterans Affairs Medical Center - Lexington — Lexington, Kentucky, United States
• Louisiana State University School of Medicine — New Orleans, Louisiana, United States
• Hubert H. Humphrey Cancer Center — Coon Rapids, Minnesota, United States
• St. Louis University Health Sciences Center — St Louis, Missouri, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.